Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-25

Clinical Trial Update: Pharmacokinetics of Apixaban in Peritoneal Dialysis

View source ↗

Summary

A study to characterize the pharmacokinetics of apixaban in patients on peritoneal dialysis with atrial fibrillation; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eliquis (apixaban)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Atrial Fibrillation | Status: RECRUITING